Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Compensatory Strategies Applied to Cognitive Impairment in Schizophrenia [NA]
A clinical trial in schizophrenia evaluating compensatory cognitive strategies has completed, providing data on non-pharmacologic approaches…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 trial evaluating the maintenance of efficacy of Risperidone Long Acting Injectable (R-LAI) in schizophrenia or schizoaffective disor…
-
CLINICAL_TRIALS research · 2013-06-24Clinical Trial Update: InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics
An observational registry of schizophrenia treatment using injectable risperidone and oral antipsychotics that has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia [Phase 3]
This document reports the completion and public posting of Phase 3 results evaluating the efficacy and safety of extended-release paliperido…
-
CLINICAL_TRIALS research · 2013-06-20Clinical Trial Update: Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia
An observational, real-world study completed to evaluate how atypical antipsychotics are allocated in the acute inpatient management of schi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Comparison of Video Consent Versus Routine Consent for Participation in Research Studies [NA]
The trial compared video consent to routine consent for participation in schizophrenia research and has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia [Phase 4]
Phase 4 clinical trial update evaluating rasagiline for persistent negative symptoms in schizophrenia; study completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome [Phase 4]
Phase 4 trial update of oral ziprasidone in metabolic syndrome patients; study terminated with results posted in 2013.
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: Occupational Therapy in the Rehabilitation of Executive Functions in Patients With Schizophrenia [NA]
This clinical trial update describes a study evaluating occupational therapy to rehabilitate executive functions in patients with schizophre…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: An Efficacy and Safety Study of Paliperidone Palmitate in Participants With Schizophrenia [Phase 3]
A Phase 3 clinical trial update reports efficacy and safety data for paliperidone palmitate in participants with schizophrenia. The results …
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients [Phase 4]
Phase 4 clinical trial update evaluating atomoxetine for weight gain in patients using olanzapine or clozapine for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype [Phase 2]
This Phase 2 trial evaluated the effects of atomoxetine on cognition and brain function in individuals with schizophrenia and memory/cogniti…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Salsalate for Insulin Resistance in Schizophrenia [NA]
Completed clinical trial investigating salsalate for insulin resistance in individuals with schizophrenia; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Rehabilitative Training for Older People With Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating rehabilitative training for older adults with schizophrenia has completed. The update notes the study st…
-
FDA approval · 2013-06-13FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for RISPERDAL (risperidone) from Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Open-label Study of Curcumin C-3 Complex in Schizophrenia [Phase 1, Phase 2]
An open-label Phase 1/2 study of Curcumin C-3 Complex in schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working Memory [NA]
A completed clinical trial evaluated the effect of repetitive transcranial magnetic stimulation on working memory in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation [Phase 4]
This Phase 4 trial evaluated whether amantadine can reduce prolactin elevations in patients treated with risperidone long-acting injectable …
-
FDA approval · 2013-06-05FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
The FDA approved a supplemental application for HALOPERIDOL DECANOATE from Patriot Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years [Phase 4]
A Phase 4 clinical trial evaluating paliperidone extended-release in adults with schizophrenia who have duration of illness less than 10 yea…
-
FDA approval · 2013-05-30FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
FDA approved a supplemental application for FANAPT (iloperidone) from Vanda Pharmaceuticals Inc. This approval pertains to a supplement to t…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Indicated Prevention of Psychotic Disorders With Low-dose Lithium [Phase 4]
Phase 4 clinical trial investigating whether low-dose lithium can prevent the onset of psychotic disorders in individuals with schizophrenia…
-
CLINICAL_TRIALS research · 2013-05-29Clinical Trial Update: Geriatric Psychiatry and Pharmacovigilance
An update on a geriatric psychiatry trial from Hannover Medical School; no trial status or results are provided. The study covers dementia, …
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder
A completed clinical trial evaluating methods for measuring smoking behavior in individuals with schizophrenia or bipolar disorder.
-
FDA label_change · 2013-05-24FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for haloperidol decanoate, resulting in changes to the labeling of this long-acting antipsychotic.